Skip to main content

Table 3 Wisepill acceptability and experiences: themes identified from end-of-study questionnaire on device use and adherence monitoring

From: Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa

 

N = 20*

Percent**

Ease of using Wisepill

 Easy to use

19

95%

 Not easy to use

1

5%

 Prefer to use Wisepill for medications

19

95%

Medication(s) easiest to take with Wisepill

 ART

14

70%

 Levofloxacin

2

10%

 Bedaquiline

10

50%

Challenges of using Wisepill

 Difficulty opening the box

3

15%

 Required extra demonstration of how to use device

1

5%

 Worry that children will find/use the device

2

10%

 Fear of missing a dose

1

5%

 Worry about losing the box during travel

1

5%

 Disconcerted by the flashing light

1

5%

 Loss of confidentiality regarding disease status

0

0%

Benefits of using Wisepill

 Maintains confidentiality regarding disease status

6

30%

 Keeps medications safe

9

45%

 Keeps medications organized

3

15%

Perception of being monitored

 Motivates to take medications

9

45%

 Induces sense of being cared for

7

35%

Popularity of Wisepill device

 Fellow patients liked the device

11

55%

 Fellow patients disliked the loss of autonomy

1

5%

 Fellow patients fear repercussions of missing dose

1

5%

 Family would react positively to the device

18

90%

 Family would be curious about the device

1

5%

Recommendations

 Increase size of pillbox to accommodate more medications

10

50%

 Alarm/reminder to take medications

5

25%

 Device should have a color

1

5%

 Device should only be given to dedicated people

1

5%

  1. *20 of the 21 enrolled patients completed an end-of-study questionnaire
  2. **Patients expressed multiple views; percent reflects (number of patients)/(total number of patients) for each statement independently